The xenoestrogen bisphenol A (BPA) is commonly ingested by humans. We examined the effects of neonatal exposure to low versus high doses of BPA over the control of estrogen receptor a (ERa) expression in the preoptic area (POA) of prepubertal female rats. Pups received s.c. injections every 48 h of BPA (high dose, 20 mg/kg and low dose, 0 . 05 mg/kg) or diethylstilbestrol (DES, 0 . 02 mg/kg) from postnatal day (PND) 1 to PND7 and were killed at PND8 or PND21. Relative expression of ERa transcripts containing alternative 5 0 -untranslated regions OS, ON, O, OT, and E1 in POA were evaluated by RT-PCR. Methylation status of ERa promoters was determined by bisulfited DNA restriction analysis and ERa protein by immunohistochemistry. In PND8, the high dose of BPA and DES diminished total ERa mRNA levels, mediated by the decreased expression of ERa-O and ERa-OT variants. In contrast, the low dose of BPA augmented total ERa mRNA by increasing the expression of the ERa-E1 variant. In PND21, both BPA doses increased total ERa mRNA by means of the augmented expression of ERa-O and ERa-OT variants. In PND21, the methylation status of the ERa promoters and the circulating levels of estradiol were similar in all experimental groups. At PND8 and PND21, DES and the high dose of BPA decreased, while the low dose of BPA increased ERa protein in the POA. These findings show that neonatal BPA exposure alters the abundance of hypothalamic ERa transcript variants and protein in a dose-dependent manner.
Introduction
Bisphenol A (BPA), one of the most common environmental endocrine disruptors with estrogenic properties, is widely employed in the manufacture of plastics used in food packaging, dental composites, and sealants (Olea et al. 1996 , Suzuki et al. 2000 . BPA is not only widespread in the environment but also commonly ingested by humans. A recent study detected measurable BPA levels in 95% of the urinary samples analyzed from people in the United States (Calafat et al. 2005) . A significant exposure of human fetuses has been reported due to BPA accumulation in maternal blood and in the amniotic fluid (Takahashi & Oishi 2000 , Ikezuki et al. 2002 , Schonfelder et al. 2002 . Although actual BPA lowest observed adverse effects level (LOAEL) established by the National Toxicology Program's report (US Environmental Protection Agency 1993) is 50 mg/kg per day, there are several reports indicating that perinatal exposure to BPA in doses below LOAEL affects reproductive parameters in adult animals, such as neuroendocrine axis development (Khurana et al. 2000 , Ramos et al. 2003 , mammary gland and prostate morphology (Ramos et al. 2001 , Durando et al. 2006 , estrous cyclicity patterns (Rubin et al. 2001) , and sexual behavior (Carr et al. 2003 , Kubo et al. 2003 , Negishi et al. 2004 , Porrini et al. 2005 , Fujimoto et al. 2006 . This apparent controversy could be explained by the fact that BPA shows an inverted-U-shaped dose-response curve (Nishizawa et al. 2005 , Wetherill et al. 2005 , Zsarnovszky et al. 2005 , where much of the effects observed with low-dose treatments are absent in traditional high-dose toxicological studies.
During perinatal brain development, estrogens are crucial for sexual differentiation of the central nervous system (Arnold & Gorski 1984) . In mammals, a-fetoprotein protects the embryonic female brain from estrogenic action (Bakker et al. 2006) by strongly binding circulating estrogens. In contrast, the perinatal male brain is exposed to high levels of estrogen, synthesized locally through the aromatization of testicular testosterone (Weisz & Ward 1980 , Corbier et al. 1992 . These sex differences in hormone synthesis and exposure during this critical period result in the development of distinct male and female neuroendocrine circuits characterized by a differential expression of hypothalamic estrogen receptors (ERs; Simerly et al. 1990 , Karolczak & Beyer 1998 . In particular, the hypothalamic preoptic area (POA) contains the anteroventral periventricular nucleus (AvPv) which is critical in the regulation of the phasic secretion of luteinizing hormone-releasing hormone in adult female rats (Polston & Simerly 2006 , Wintermantel et al. 2006 .
Akin to endogenous testosterone, the synthetic estrogen diethylstilbestrol (DES) and BPA show a very weak binding affinity to a-fetoprotein (Savu et al. 1979 , Milligan et al. 1998 , Nagel et al. 1999 and are therefore potential disruptors of hypothalamus development.
For many genes, it has been demonstrated that untranslated regions (UTRs) can differentially determine protein expression by influencing mRNA stability (Sharp & Bechhofer 2005 ) and translational efficiency (Gauss et al. 2006) . These UTRs can determine tissue-specific expression through the regulatory action of multiple cis-acting motifs (Contractor et al. 2004) . Some of the more frequent regulatory cis-acting motifs that are present close to the transcription start sites are the repetitive CG-rich elements called CpG islands. These regions act as molecular switches that activate or deactivate transcription initiation through differential methylation mechanisms (Sasaki et al. 2003 , Champagne et al. 2006 . In the rat, it has been described that a system of untranslated first exons is associated with the promoter selection for ERa transcription initiation, and to date five active promoters called OS, ON, O, OT, and E1 (Koike et al. 1987 , Hirata et al. 1996a ,b, Donaghue et al. 1999 , Osada et al. 2001 ) have been identified. Little is known about the precise function of each ERa promoter; however, it has been reported that a mechanism of promoter selection is involved in the complex stage-and region-specific regulation of ERa gene expression in many organs, including the rat brain (Kato et al. 1998 , Hamada et al. 2005 .
Since ERa mRNA transcription and maturation could be differentially regulated by estrogens (Varayoud et al. 2005) , it is very interesting to know whether high and low doses of xenoestrogens can modify the differential usage of ERa gene promoters in the rat hypothalamus. Using rats exposed early in life, we examined the effects of DES and BPA over the control of ERa transcription and translation in the hypothalamic POA of prepubertal female rats. Furthermore, we studied the relative abundance of ERa transcripts with alternative 5 0 UTR exons and the methylation status of ERa gene promoters in prepubertal female rats in response to xenoestrogen exposure.
Material and Methods

Animals and experimental design
Pups were obtained from timed-pregnant Wistar rats housed under a controlled environment (22G2 8C; lights on from 0600 to 2000 h) with free access to pellet laboratory chow (Cooperació n, Buenos Aires, Argentina) and tap water supplied from glass bottles. All rats were handled in accordance with the principles and procedures outlined in the Guide for the Care and Use of Laboratory Animals issued by the US National Academy of Sciences.
DES and BPA were purchased from Sigma-Aldrich. At least eight, and up to ten, timed-pregnant dams were used to collect offspring for each treatment (see below). At delivery (postnatal day 0, PND0), pups were sexed according to anogenital distance and cross-fostered, distributing pups of each litter between different mothers. These actions allowed us to minimize the use of siblings to avoid potential litter effects. The cross-fostered litters were adjusted to ten pups (five females and five males whenever possible) and assigned to one out offour experimental groups: corn oil vehicle-treated pups (control females and control males), DES (female pups injected with DES 0 . 02 mg/kg), BPA05 (female pups injected with a low dose of BPA 0 . 05 mg/kg), and BPA20 (female pups injected with a high dose of BPA 20 mg/kg). All pups received s.c. injections every 48 h from PND1 to PND7, with either 40 ml corn oil alone or 40 ml corn oil containing the appropriate amount of DES or BPA. Control males were used as a reference of natural masculinization of the POA and were treated as another experimental group. Based on the US Environmental Protection Agency (US EPA) estimate, the LOAEL for oral exposure to BPA in rats is 50 mg/kg per day (US Environmental Protection Agency 1993). Experts from the National Toxicology Program's subpanel suggested a cutoff dose of 5 mg/kg per day for low-dose effects, regardless of the administration route, the duration of exposure or the age/life stage at which exposure occurred (National Toxicology Program 2001 http:// ntp.niehs.nih.gov/ntp/htdocs/liason/LowDosePeerFinalRpt. pdf). Taking into account the above-mentioned concepts, the high dose of BPA used in our study is four times bigger than the low-dose cutoff suggested by the US EPA experts and 2 . 5-fold smaller than the LOAEL; meanwhile, the low dose is 100 times smaller than the low-dose cutoff and is similar to the acceptable daily intake level established by the US Environmental Protection Agency (1993 http://www.epa.gov/iris/subst/ 0536.htm). No signs of acute or chronic toxicity were observed, and no significant differences in weight gain and anogenital distance between treated and control pups were recorded during the experiment (data not shown). Alterations in maternal care were not detected between experimental groups. Pups from a single mother were killed by decapitation on PND8 or PND21, trunk blood collected, and serum stored at K20 8C until used for hormone assay. The number of animals per group at each time point evaluated was w12-14.
For immunohistochemistry, brains were microdissected and fixed by immersion in 4% paraformaldehyde for 24 h at 4-8 8C. Fixed tissue was dehydrated in an ascending series of ethanol, cleared in xylene, and embedded in paraffin. Serial 5 mm thick frontal sections encompassing the medial POA in the coronal plane (Paxinos & Watson 2005) were mounted on 3-aminopropyl triethoxysilane (Sigma-Aldrich) coated slides and dried for 24 h at 37 8C.
For nucleic acid extraction, brain tissue blocks containing the POA were quickly microdissected under a GZ6 series dissecting microscope (Leica Corp., Buffalo, NY, USA).
The POA fragment was encompassed by the anterior portion of the anterior commissure, the beginning of the ascending optical tracts, dorsally by the ventral portion of the anterior commissure, and laterally by a virtual line that is projected from the internal capsule to the external edge of the optical tracts (Paxinos & Watson 2005) . After removal, tissue samples were immediately frozen in liquid nitrogen and stored at K80 8C until used for RNA or DNA analysis.
RT and real-time quantitative PCR analysis
An optimized PCR protocol was employed to analyze the relative expression levels of total ERa mRNA and ERa transcripts containing the untranslated first exons OS, ON, O, OT, and E1 (see Fig. 1A and Table 1 ). Four pools of two PND8 POA brain blocks (nZ4) or four to six individual PND21 blocks (nZ4-6) of each experimental group were homogenized in TRIzol reagent and total RNA was extracted following the manufacturer's protocol (Invitrogen). The concentration of total RNA was assessed by A 260 and the sample was stored at K80 8C until needed. Equal quantities (4 mg) of total RNA were reverse-transcribed for 90 min at 42 8C using 200 pmol random hexamer primers (Promega), 100 nmol deoxy-NTPs, and 300 U Moloney Murine Leukemia Virus reverse transcriptase (MMLV-RT, Promega) in a final volume of 30 ml of 1! MMLV-RT buffer. A sample without reverse transcriptase was included to detect genomic DNA contamination. Each reverse-transcribed product was diluted with RNAse free water to a final volume of 60 ml and further amplified in triplicate using the Real-Time DNA Engine Opticon System (Bio-Rad Laboratories) and SYBR Green I dye (Cambrex Corp., East Rutherford, NJ, USA). Primer sequences used for amplification of ERa, 18sRNA, and ERa promoters cDNA's are shown in Table 1 .
For amplifications, 5 ml cDNA were combined with a mixture containing 2 . 5 U Platinum Taq-DNA polymerase (Invitrogen), 2 mM MgCl 2 (Invitrogen), 0 . 2 mM of each of the four dNTPs (Promega), 1 ml of 10!SYBR Green I, and 10 pmol of each primer (Invitrogen) in a final volume of 25 ml of 1!PCR buffer. Product purity was confirmed by dissociation curves and random agarose gel electrophoresis. Controls containing no template DNA were included in all assays, yielding no consistent amplification. The cycle threshold (C T ) for each sample was calculated using the Opticon Monitor Analysis Software (MJ Research, Bio-Rad Laboratories) with an automatic fluorescence threshold setting. Calculation of relative expression levels of each target was conducted based on the 2 KDDCT method (Higuchi et al. 1993) . The efficiency of PCRs was assessed for each target by amplification of serial dilutions (over five orders of magnitude) of cDNA fragments of the transcripts under analysis. No significant differences in C T values were observed for 18sRNA between the different experimental groups. All PCR products were cloned using the TA cloning kit (Invitrogen) and specificity was confirmed by DNA sequencing (data not shown).
DNA extraction and bisulfite modification
DNA was isolated from pools of three POA tissue blocks of each PND21 group using the Wizard Genomic DNA Purification Kit (Promega). DNA (2 mg) in a volume of 50 ml was denatured with NaOH for 20 min at 37 8C. Thirty microliters of 10 mM hydroquinone (Sigma-Aldrich) and 520 ml of 3 M sodium bisulfite (Sigma-Aldrich) at pH 5, both freshly prepared, were added and mixed, and samples were incubated in the dark under a mineral oil layer at 55 8C for 16 h. Modified DNA was purified using Wizard DNA purification resin according to the manufacturer (Promega) and eluted into 50 ml preheated water (65 8C). Modification was completed by NaOH treatment for 15 min at 37 8C and followed by overnight ethanol precipitation. DNA was dissolved in 20 ml DNAse free water and used immediately or stored at K20 8C.
Combined bisulfite restriction analysis (COBRA)
In COBRA (Xiong & Laird 1997) , restriction enzyme digestion is employed to reveal DNA methylation-dependent sequence differences (Fig. 1B) in PCR-amplified bisulfitetreated genomic DNA. Using the MethPrimer software (Li & Dahiya 2002) , we identified CpG-rich fragments (CpG islands) on the stage-and region-specific active ERa gene promoters O and OT, and in ERa gene exon 1 (Fig. 1C , see Results) but not on promoter E1 or on the inactive promoters OS and ON. For COBRA purposes, these CpG islands were checked to contain at least one restriction site for Bst UI and/ or Taq I enzymes (Fig. 1C) . PCR primers were designed to encompass CpG islands and to complement the bisulfiteconverted DNA (Fig. 1C , Table 2 ). The PCR mixture contained 2 mM MgCl 2 (Invitrogen), 0 . 2 mM of each of the four dNTPs (Promega), 10 pmol of each primer (Invitrogen), and bisulfite-modified DNA (1 ml) in a final volume of 25 ml of 1!PCR buffer. Reactions were hot-started at 95 8C for 10 min before the addition of 2 . 5 U Taq-DNA polymerase (Invitrogen). Amplification was carried out for 36 cycles (45 s at 95 8C, 45 s at 59 8C, and 1 min at 72 8C), followed by a final 2 min extension at 72 8C. Controls with unmodified DNA and without DNA were performed for each set of primers. To ensure complete digestion of the PCR products in the subsequent restriction digestion step, each PCR product (20 ml) was loaded onto 2% agarose gel containing ethidium bromide (Sigma-Aldrich), quickly visualized under u.v. illumination and purified using the Wizard SV Gel and clean-up System kit according to the manufacturer's protocol (Promega). Fifteen microliters of each purified PCR product was then digested separately with Bst UI (recognition site CGCG) and Taq I (recognition site TCGA). Cleavage will occur only if the CG sequence has been retained during the bisulfite conversion by a methylated cytosine residue (Fig. 1B) . To ensure that the bisulfite conversion was complete, a control digest was performed with MseI (recognition site TTAA, data not shown). The molecular sizes of PCR and restriction products were determined by comparison with DNA standard size markers (Cien Marker, Biodynamics, Buenos Aires, Argentina).
ERa expression detected by immunohistochemistry
A standard immunohistochemical technique (avidin-biotinperoxidase) was used to visualize ERa immunostaining intensity and distribution following a previously described protocol (Munoz de Toro et al. 1998 , Varayoud et al. 2005 . Overnight incubation at 4 8C was performed by applying a diluted mouse monoclonal antibody raised to full-length recombinant human ERa (working dilution 1:200; clone 6F-11, Novocastra, Newcastle upon Tyne, UK), followed by incubation with a biotinylated secondary antibody (working dilution 1:80; Sigma-Aldrich). Negative controls were obtained by replacing the primary antibody with nonimmune mouse serum (Sigma-Aldrich). The reaction was then developed using diaminobenzidine-nickel (Sigma-Aldrich) as a cromogen substrate. Samples were dehydrated and mounted with permanent mounting medium (PMyR, Buenos Aires, Argentina).
Quantitation of ERa expression in the AvPv of POA by image analysis
Image analysis was performed using the Image Pro-Plus 4.1.0.1 system (Media Cybernetics, Silver Spring, MA, USA) as previously described (Ramos et al. 2002) . In brief, the images were recorded by a Spot Insight V3.5 color video camera, attached to an Olympus BH2 microscope (illumination, 12 V halogen lamp and 100 W, equipped with a stabilized light source), using a D-plan 10!objective (NAZ0 . 25). The microscope was set up properly for Koehler illumination. Correction of unequal illumination (shading correction) and the calibration of the measurement system were done with a reference slide. Four brains from PND8 killed pups (nZ4) and five brains from PND21 prepubertal animals (nZ5) were scored in each experimental group. Typically, six or more sections of a one-in-six series were scored and averaged per animal. The images of immunostained slides were converted to a grey scale, the AvPv nucleus of POA was delimited according to Paxinos & Watson (2005) . The integrated optical density (IOD) was measured as a linear combination between the average grey intensity and the relative area occupied by positive cells. This morphometric approach provides more reproducibility, since relative spatial variables are independent of oversampling errors that would be incurred in calculating the absolute volumes and total cell numbers (Gundersen et al. 1988 , Palmer et al. 2000 , Ramos et al. 2001 .
Hormone assay 17b-estradiol (E 2 ) concentrations were determined by RIA using [2,4,6,7,16,17-3H(N) ]E 2 (Perkin-Elmer Life and Analytical Sciences, Boston, MA, USA) and a specific antibody provided by Dr G D Niswender. Pools consisting of two individual PND21 serum samples were made, and five pools of each experimental group were used. The sensitivity of the assay was 12 . 5 pg/ml. Intra-and inter-assay coefficients of variation were 3 . 38 and 2 . 12% respectively.
Data analysis
Statistical analyses were performed using two-tailed t tests. Each experimental group was compared against control females only, and differences were considered significant at P!0 . 05.
Results
Effects of low and high doses of BPA on the preoptic ERa mRNA expression
In PND8, control females showed higher expression of ERa mRNA in the hypothalamic POA than control males (P! 0 . 05, Fig. 2A ). Females exposed to DES were defeminized and ERa mRNA expression was significantly reduced and similar to male pups (P!0 . 01, Fig. 2A ). BPA treatment showed opposite and dose-dependent effects: in BPA20-treated females ERa mRNA expression levels decreased about fourfold when compared with control females (P! (BPA05) increased 1 . 4-fold their hypothalamic ERa mRNA content (P!0 . 05, Fig. 2A ).
To know if the alterations observed in PND8 were of a transient or permanent nature, we assessed ERa mRNA expression 2 weeks after the end of the postnatal treatment. On PND21 -in contrast from the PND8 findings -the hypothalamic ERa mRNA content in control females, control males, and DES-treated females was similar (Fig. 2B) . Surprisingly, on PND21 in both BPA-exposed groups, ERa mRNA expression was clearly augmented (P!0 . 05, Fig. 2B ) in a dose-independent fashion. It is interesting to note that the high levels of ERa mRNA expression observed on PND8 in BPA05-treated females persisted up to PND21, increasing to just about 2 . 1-fold (P!0 . 05, Fig. 2B ) when compared with female controls.
BPA changes the relative abundance of ERa transcripts with alternative 5 0 UTRs
To determine whether total POA ERa mRNA expression changes were associated with changes in transcriptional promoter usage, relative expression levels of all exons encoding 5 0 UTR of the rat ERa gene were studied using a real-time PCR approach. Specific sense primers for ERa 5 0 -untranslated exons OS, ON, O, OT, E1 and a common antisense primer specific for ERa exon 1 were designed (Table 1, Fig. 1A ). Optimal reaction conditions for all transcript variants were first evaluated in cDNA from an intact adult female uterus and in all reactions, a single band of the expected size was obtained (Fig. 3) . We determined that ERa gene transcription in POA is regulated by means of promoters OT, E1, and O (Fig. 3) , despite age or treatment group. Expression of transcripts containing the ON or OS exons could not be detected in POA at any time point studied.
At PND8, ERa 5 0 UTR variant expression in the POA showed a great sexual dimorphism, since control females showed higher levels of ERa-OT, ERa-O, and ERa-E1 transcripts than male pups (P!0 . 05, Fig. 4A-C) . DEStreated females presented diminished ERa-OT and ERa-O transcription rates when compared with female controls (P!0 . 05, Fig. 4A and B), together with a significant 1 . 6-fold increase in the ERa-E1 transcript variant expression (P!0 . 05, Fig. 4C ). BPA exposure showed a dosedependent perturbation of ERa 5 0 UTR variant expression. When compared with female control pups and like DES-treated rats, the high dose of BPA (BPA20) clearly diminished ERa-OT and ERa-O transcript content (P!0 . 01, Fig. 4A and B) and augmented the ERa-E1 variant expression (P!0 . 05, Fig. 4C ). Females exposed to the low dose of BPA (BPA05) showed no changes in the ERa-OT and ERa-O transcript content and only a 1 . 6-fold significant rise in the ERa-E1 transcript variant (P!0 . 05, Fig. 4A-C) .
In prepubertal PND21 females, a different pattern of ERa transcript variants was detected following xenoestrogen exposure. ERa-O and ERa-OT transcripts were significantly increased in DES-(P!0 . 01), BPA20-(P!0 . 01), and BPA05-(P!0 . 005, Fig. 4D and E) treated females. Regarding the exon-E1 mRNA variant, a twofold decrease in BPA20-(P! 0 . 01) and BPA05-(P!0 . 05) treated animals were found (Fig. 4F) . It is important to note that at this time point, no differences between male and female controls were observed in ERa 5
0 UTR variant transcription rates (Fig. 4D-F ).
Methylation status of ERa transcriptional promoters in prepubertal female rats
To find out if DES-and BPA-induced changes in alternative 5 0 UTR ERa transcript levels are being caused through a DNA methylation mechanism, we used a COBRA approach to determine the methylation status of transcriptionally active promoters in prepubertal PND21 animals. In all experimental groups, exon 1 and promoter ERa-O were completely unmethylated, while the ERa-OT promoter presented a constitutive, treatment-independent, low level of methylation in the CpG island, as evaluated by Bst UI restriction analysis (Fig. 5) . We could not find differences in the CpG methylation status of active ERa promoters between experimental groups.
Differential ERa protein expression in the AvPv
To determine if alterations prompted by postnatal xenoestrogen exposure in ERa mRNA expression were extensive in the ERa protein, we determined the relative ERa protein levels in PND8 and PND21 rats in neurons from the AvPv nucleus ( Fig. 6A-J) . On PND8, ERa protein levels were significantly reduced in the AvPv (P!0 . 005, Fig. 6K ) of male pups and in DES-and BPA20-treated females when compared with female controls. In contrast, the AvPv of females exposed to the low dose of BPA showed a clear increase in ERa protein expression (P!0 . 001). Two weeks after exposure, ERa expression levels remained significantly reduced in male controls, as well as DES-and BPA20-treated females (P!0 . 001, Fig. 6L ), whereas in BPA05-treated rats, ERa IOD levels were still significantly increased with respect to female controls (P!0 . 05).
E 2 serum levels remain unaltered in prepubertal females postnatally exposed to BPA and DES No differences in E 2 serum levels were observed between prepubertal PND21 rats of all experimental groups (Fig. 7) .
Note that control female and control males E 2 serum levels were similar at this time point.
Discussion
To our knowledge, this is the first study showing that neonatal BPA exposure affects the relative abundance of alternative 5 0 UTRs ERa transcripts in the female rat POA. Furthermore, female rats exposed to the high dose of BPA downregulated the expression of total ERa mRNA, while L MONJE and others . Effects of neonatal BPA exposure females exposed to a dose of 400 times smaller presented the opposite effect. Two weeks after the end of the xenoestrogen exposure, the ERa mRNA hypothalamic expression remained significantly high in both BPA-treated groups, suggesting a long-term effect. Alterations caused by early postnatal BPA exposure are not restricted to ERa transcription, but are extensive in ERa translation in the sexually dimorphic AvPv nucleus of POA. When female rats were analyzed immediately after the end of the high-dose BPA exposure (PND8), an abrupt decrease in ERa protein levels was observed. Surprisingly, the low-dose BPA exposed animals showed a significant upregulation of the ERa protein, clearly showing an opposite dose-dependent effect of BPA on the transcription and translation control of the ERa gene in the female POA. Taken together, the above-mentioned findings suggest that the high dose of BPA, like DES treatment, provoke defeminization of ERa expression in the POA of female offspring, which is consistent with the estrogenic nature of BPA (Olea et al. 1996) . Remarkably, the opposite effect was seen in the low dose-exposed females, suggesting that the estrogenic action of BPA is an emergent property that depends on the experimental context complexity. In lower complexity contexts, like in vitro experimental conditions, the estrogenic or antiestrogenic qualities of a substance are robustly determined; however, in in vivo conditions, the estrogenic or antiestrogenic action is an emergent phenomena dependent on multiple variables like doses, end-points evaluated, animal genomic background, etc. (vom Saal & Hughes 2005) . Specifically, the results obtained in the high-dose BPA group on PND21 could indicate an over compensation mechanism that take place in response to the initial ERa reduction observed on PND8. In a previous work (Ramos et al. 2007) , we found a similar over-compensation mechanism in the control of estrogendependent genes in the hippocampus of rat neonatally exposed to xenoestrogens. These results suggest the existence of an internal regulatory mechanism to compensate an initial xenoestrogen-induced declination of estrogen-dependent gene transcription.
A possible mechanism involved in the xenoestrogenmediated ERa disruption could include differential promoter usage, as evidenced by changes in the relative abundance of alternative spliced 5 0 UTR transcripts (Kato et al. 1998 , Hughes 2006 . Our results show that the reduction in ERa mRNA expression observed in newborn females exposed to the high dose of BPA is correlated with low levels of ERa-O and ERa-OT transcripts. Otherwise, in newborn females exposed to the lower dose of BPA, the increase observed on ERa transcription could be explained by the increment in transcripts from promoter ERa-E1 and the unaltered transcription levels from promoters ERa-O and ERa-OT. It is interesting to note that even though newborn females exposed to the high dose of BPA also presented an increment in transcripts from promoter ERa-E1, which does not seem to be enough to balance the low levels of promoters O and OT activity. On PND21-treated females, both doses of BPA induced an approximately twofold upregulation in total ERa mRNA levels, which was mediated by means of the increased expression of ERa-O and ERa-OT variants. These results strongly suggest that the ERa-OT and ERa-O promoters are very important in ERa transcription control during the early postnatal period in hypothalamic structures.
The selective promoter usage in estrogen-mediated ERa transcriptional regulation has been demonstrated in several breast cancer cell lines (Donaghue et al. 1999) and in rat brain (Hamada et al. 2005) . Moreover, differential promoter activity has been shown to be a key regulator of tissue-specific ERa expression (Kato et al. 1998 , Donaghue et al. 1999 . Here, we suggest that the alternative promoter usage of the ERa gene is regulated by BPA exposure in a dose-sensitive manner and therefore this mechanism could be, at least in part, responsible for the different and sometimes contradictory effects observed in BPA action on gene transcription (Khurana et al. 2000 , Kwon et al. 2000 , Aloisi et al. 2001 , Ramos et al. 2003 , Patisaul et al. 2006 . Since sexual differentiation of the hypothalamus is estrogen-dependent and mediated at least partly through ERa (Simerly et al. 1997) , BPA deregulation of this receptor could affect the natural estrogen-directed dimorphisms of POA circuits. In a previous work performed in our laboratory, it has been demonstrated that low and high doses of estrogen can differentially regulate the splicing of the rat ERa mRNA coding region (Varayoud et al. 2005) . Selective promoter usage and alternative mRNA splicing events are estrogen-dependent mechanisms of ERa gene variation, arising as sources of complexity in the endocrine disruptor's toxicology. In every particular experimental paradigm, it is very difficult to predict if BPA-mediated disruptions would be similar to those observed in natural or synthetic estrogen exposure experiments (vom Saal & Hughes 2005 , vom Saal & Welshons 2006 . The results obtained here clearly show that BPA acts as a classical estrogen (like DES), defeminizing the ERa protein expression of females' POA only in the high-dose experiment, whereas the low-dose Figure 7 Estradiol serum levels in prepubertal animals. Blood was collected on PND21 and analyzed for 17b-estradiol. Each value is the meanGS.E.M. of five serum samples per treatment group. effect is exactly the opposite. These events could be associated with the BPA property to modulate different promoter regions of regulatory genes (like ERa) in a dose-dependent manner. The molecular mechanism underlying this promoter selection is not known and is under study in our laboratory. The sequences of the ERa-O and ERa-OT promoters possess a small 5
0 -upstream open reading frame (5 0 upORF). Several regulatory roles have been assigned to these 5 0 upORF, such as limiting the protein expression by a translation reinitiation mechanism (Kos et al. 2002 , Blaschke et al. 2003 . Further research will help to elucidate if any of these mechanisms are involved in the xenoestrogen regulation of ERs in the rat hypothalamus.
Early developmental perturbations due to xenoestrogen exposure have been linked to the adult-onset of reproductive pathologies, including cancer , Durando et al. 2006 ; however, the molecular basis for this imprinting event is not known. A recent report showed that neonatal estradiol or BPA exposure causes early and prolonged hypomethylation of the 5 0 -flanking region of the phosphodiesterase type 4 gene (PDE4D4) in the rat prostate gland, resulting in continued and elevated PDE4D4 expression (Ho et al. 2006) . Using COBRA, we could not find any differences in the methylation status of the active ERa promoters between xenoestrogen-treated and control groups, suggesting that DES and BPA alter the hypothalamic ERa gene transcription control using a methylationindependent mechanism.
The results presented here are in accordance with a recently published report where it was evidenced that exposing female rats during the first PNDs to a high dose of BPA (100 mg/kg per day) causes a significant decrease in tyrosine-hydroxylase (TH) and ERa double-labeled neurons in the AvPv (Patisaul et al. 2006) . In another work, CD-1 mice treated with low doses of BPA (25 and 250 ng/kg per day) from day 8 of gestation through day 16 of lactation clearly decreased the number of TH neurons in the AVPV (Rubin et al. 2006) . Moreover, the fact that E 2 serum levels in prepubertal females are not affected by postnatal BPA exposure suggests that the disruptions observed 2 weeks after the end of xenoestrogen treatment could be attributed to an organizational disruption in the transcription control of estrogen-sensitive genes like TH and ERa rather than disturbances in the endogenous estradiol.
Our findings are consistent with an inverted-U-shaped dose-response curve previously reported for BPA hormone action (Nishizawa et al. 2005 , vom Saal & Hughes 2005 , Wetherill et al. 2005 , Zsarnovszky et al. 2005 . Alarmingly, the lower BPA concentration used in this study (50 mg/kg) falls in the expected human exposure range, as microgram quantities of BPA were detected in urinary samples of a reference human population (Calafat et al. 2005) and in early pregnancy amniotic fluid (Ikezuki et al. 2002 , Engel et al. 2006 . This is of particular concern to fetus health, where subtle alterations will probably remain undiscovered until the onset of sexual maturity. It was clearly shown that in utero exposure to environmental doses of BPA affects the hypothalamicpituitary axis, increasing POA ERb mRNA expression and prolactin levels in male offspring as well as LH secretion and estrous cyclicity in females (Rubin et al. 2001 , Ramos et al. 2003 . Moreover, xenoestrogen exposition in newborns is expected to continue as BPA is released from polycarbonate baby bottles (Brede et al. 2003) and is also present in regular powdered infant and follow-up formulas (Kuo & Ding 2004) .
Our results show that BPA exposure during the early postnatal period alters the abundance of hypothalamic ERa transcript variants and protein in a dose-dependent manner. Based on present data and previous reports, we could suggest that xenoestrogen exposure during critical periods of development disrupt hypothalamic gene expression, interfering with the normal maturation of sexually dimorphic areas of the forebrain. Actually, we are evaluating the consequences of the xenoestrogen-induced ERa disruption on the gonadotropin-releasing hormone neurocircuitry In summary, a comprehensive analysis is needed to evaluate the potential hazards to humans and wildlife from exposure to BPA at doses below the prior LOAEL dose of 50 mg/kg per day.
